The provision of pharmaceutical advice improves patient vaccination status
- PMID: 25214905
- PMCID: PMC4155618
- DOI: 10.4321/s1885-642x2006000400003
The provision of pharmaceutical advice improves patient vaccination status
Abstract
Aim: To increase vaccination rates in the wealthy industrial nation of Germany. For a variety of reasons there is a substantial deficit in the number of individuals who receive vaccinations in comparison with other industrialized countries.
Methods: In Autumn 2003, a regional vaccination consultation was initiated over a five-week period. Individuals involved in the study provided general information, including their age, health status, and vaccination records, and received an extensive consultation in a pharmacy in Jena, Germany. Participants were provided with a written overview of their vaccination status. After approximately five weeks, the vaccination status of each individual was recorded.
Results: 312 of 2500 patients received intensive vaccination education based on their accompanying vaccination documentation. Older individuals, who are known for having the largest vaccination gap in Germany, represented the highest percentage of people who used this service. The five most commonly required vaccinations had increased significantly, five weeks after the consultation. These vaccination rate increases included diphtheria, which rose from 55.8 to 71.2%, tetanus, which rose from 73.1 to 86.5%, influenza, which rose from 46.5 to 74.7%, pneumococcal, which rose from 32.4 to 62.8%, and tick-borne encephalitis, which rose from 31.9 to 42.4% (all p<0.008).
Conclusions: Well structured vaccination consultations help to raise vaccination rates. Thus, pharmacies should consider offering and implementing this preventive measure so as to lower the rates of preventable disease and to save costs.
Keywords: Counseling; Germany; Patient Education; Pharmacists; Vaccination.
Similar articles
-
Evaluation of Pharmacist-Initiated Interventions on Vaccination Rates in Patients with Asthma or COPD.J Community Health. 2018 Apr;43(2):297-303. doi: 10.1007/s10900-017-0421-9. J Community Health. 2018. PMID: 28852915
-
Pharmacist-led Tdap vaccination of close contacts of neonates in a women's hospital.Vaccine. 2014 Jan 16;32(4):521-5. doi: 10.1016/j.vaccine.2013.11.035. Epub 2013 Nov 20. Vaccine. 2014. PMID: 24269619
-
Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations.Vaccine. 2011 Oct 19;29(45):8073-6. doi: 10.1016/j.vaccine.2011.08.051. Epub 2011 Aug 22. Vaccine. 2011. PMID: 21864625
-
The Role of Community Pharmacists in Travel Health and Vaccination in Switzerland.Pharmacy (Basel). 2018 Nov 29;6(4):125. doi: 10.3390/pharmacy6040125. Pharmacy (Basel). 2018. PMID: 30501076 Free PMC article. Review.
-
Does policy change to allow pharmacist provision of influenza vaccination increase population uptake? A systematic review.Aust Health Rev. 2020 Aug;44(4):582-589. doi: 10.1071/AH19196. Aust Health Rev. 2020. PMID: 32674753
Cited by
-
Review of services provided by pharmacies that promote healthy living.Int J Clin Pharm. 2012 Jun;34(3):399-409. doi: 10.1007/s11096-012-9634-2. Epub 2012 Apr 17. Int J Clin Pharm. 2012. PMID: 22527479
-
"It's easier in pharmacy": why some patients prefer to pay for flu jabs rather than use the National Health Service.BMC Health Serv Res. 2014 Jan 24;14:35. doi: 10.1186/1472-6963-14-35. BMC Health Serv Res. 2014. PMID: 24456532 Free PMC article.
-
Patient reminder and recall interventions to improve immunization rates.Cochrane Database Syst Rev. 2018 Jan 18;1(1):CD003941. doi: 10.1002/14651858.CD003941.pub3. Cochrane Database Syst Rev. 2018. PMID: 29342498 Free PMC article.
-
The role of community pharmacy-based vaccination in the USA: current practice and future directions.Integr Pharm Res Pract. 2015 Jul 1;4:67-77. doi: 10.2147/IPRP.S63822. eCollection 2015. Integr Pharm Res Pract. 2015. PMID: 29354521 Free PMC article. Review.
References
-
- Global Polio Eradication Initiative: The poliomyelitis history. [accessed 24th July 2006]; http://www.polioeradication.org/history.asp .
-
- Rychlik R, Heinen-Kammerer T, Rusche H, Piercy J, Scuffham P, Zöllner Y. Kosteneffektivität der Prophylaxe und Behandlung von Influenza. Dtsch Med Wochenschr. 2003;128:2267–70. - PubMed
-
- Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, Lilac HA, Hall H, Klimov A, Fukuda K. Effectiveness and cost-benefit of influenza vaccination of healthy working adults - a randomized controlled trial. JAMA. 2000;284:1655–63. - PubMed
-
- Nichol KL, Goodman M. Cost effectiveness of influenza vaccination for healthy persons between ages 65 and 74 years. Vaccine. 2002;20:21–4. - PubMed
-
- Nichol KL, Baken L, Wuorenma J. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med. 1999;159:2437–42. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous